نتایج جستجو برای: malignant gliomas

تعداد نتایج: 219260  

Journal: :Onkologie 2001
M Kirsch T Santarius P M Black G Schackert

Malignant brain tumors, especially malignant gliomas, have a poor prognosis, a fact which has remained unchanged over the last decades despite the employment of multimodal therapeutic approaches. Malignant gliomas are among the most vascularized tumors known and the amount of vascularization has been correlated to their prognosis. Since tumor growth is dependent on concomitant vascularization, ...

Journal: :Molecular cancer therapeutics 2014
Maija Hyvönen Juulia Enbäck Tuulia Huhtala Johanna Lammi Harri Sihto Janne Weisell Heikki Joensuu Katri Rosenthal-Aizman Samir El-Andaloussi Ulo Langel Ale Närvänen Gabriele Bergers Pirjo Laakkonen

Malignant gliomas are associated with high mortality due to infiltrative growth, recurrence, and malignant progression. Even with the most efficient therapy combinations, median survival of the glioblastoma multiforme (grade 4) patients is less than 15 months. Therefore, new treatment approaches are urgently needed. We describe here identification of a novel homing peptide that recognizes tumor...

Journal: :Journal of neurosurgery 2010
Neysan Rafat Grietje Ch Beck Jutta Schulte Jochen Tuettenberg Peter Vajkoczy

OBJECT Recent experimental work suggests that circulating endothelial progenitor cells (cEPCs) are recruited to the angiogenic vascular system of malignant gliomas. Consequently, the level of cEPCs has been proposed as a novel biomarker for the diagnosis and monitoring of these lesions. The aim of the present study was to examine the level of cEPCs and the level of EPC mobilizing mediators in t...

Journal: :Annals of palliative medicine 2021

: Gliomas represent the majority of malignant central nervous system tumors, with most aggressive subtype, glioblastoma, accounting for almost 57% this entity. Type glioma and its incidence can vary depending on age presentation. In turn, outcomes significantly based actual type (histologically molecularly) patient, as well various tumor specific factors such size, location, comorbidities, etc....

2015
Tanja Mesti Maja Ebert Moltara Marko Boc Martina Rebersek Janja Ocvirk

BACKGROUND Treatment options of recurrent malignant gliomas are very limited and with a poor survival benefit. The results from phase II trials suggest that the combination of bevacizumab and irinotecan is beneficial. PATIENTS AND METHODS The medical documentation of 19 adult patients with recurrent malignant gliomas was retrospectively reviewed. All patients received bevacizumab (10 mg/kg) a...

2014
Rafay Ahmed Matthew J Oborski Misun Hwang Frank S Lieberman James M Mountz

Malignant gliomas consist of glioblastomas, anaplastic astrocytomas, anaplastic oligodendrogliomas and anaplastic oligoastrocytomas, and some less common tumors such as anaplastic ependymomas and anaplastic gangliogliomas. Malignant gliomas have high morbidity and mortality. Even with optimal treatment, median survival is only 12-15 months for glioblastomas and 2-5 years for anaplastic gliomas....

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Hiroaki Wakimoto Shota Tanaka William T Curry Franziska Loebel Dan Zhao Kensuke Tateishi Juxiang Chen Lindsay K Klofas Nina Lelic James C Kim Dora Dias-Santagata Leif W Ellisen Darrell R Borger Sarah-Maria Fendt Matthew G Vander Heiden Tracy T Batchelor A John Iafrate Daniel P Cahill Andrew S Chi

PURPOSE Isocitrate dehydrogenase (IDH) gene mutations occur in low-grade and high-grade gliomas. We sought to identify the genetic basis of malignant phenotype heterogeneity in IDH-mutant gliomas. METHODS We prospectively implanted tumor specimens from 20 consecutive IDH1-mutant glioma resections into mouse brains and genotyped all resection specimens using a CLIA-certified molecular panel. G...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
M Bredel I F Pollack R L Hamilton C D James

Epidermal growth factor receptor (EGFR) is commonly overexpressed in adult high-grade gliomas. Forty to 50% of such tumors demonstrate amplification of the EGFR gene, often with rearrangement and constitutive activation of the gene product, suggesting that EGFR might play a role in the malignant progression of a subset of these neoplasms. In this regard, several groups have shown that overexpre...

2015
Dong Zhong Jianhua Ran Xiaodong Zhang Yun Tan Guijie Chen Wenyuan Tang Xiaosong Li Bing Wang

INTRODUCTION Invasion is usually recognized as the main reason for the high recurrence and death rates of gliomas. Therefore, properly understanding the molecular mechanisms of migration and invasion of human gliomas has become a focus and will be helpful for the treatment of gliomas. Syntenin has been demonstrated to be implicated in the migration, invasion and metastasis of many types of mali...

Journal: :Neuro-oncology 2022

Abstract Gliomas have been classified into molecular (proneural, classical, mesenchymal) and neurodevelopmental (astrocyte, mesenchymal, neural progenitor cell (NPC), oligodendrocyte (OPC)) subtypes describing inter- intra-tumoral heterogeneity; however, the functional outcomes therapeutic implications of these has yet to be fully described. Metabolic reprogramming is a hallmark cancer, maligna...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید